4-hydroxyphenylacetic acid has been researched along with alendronate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arns, S; Gibe, R; Monzur Morshed, M; Moreau, A; Young, RN | 1 |
1 other study(ies) available for 4-hydroxyphenylacetic acid and alendronate
| Article | Year |
|---|---|
Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis.
Topics: Alendronate; Animals; Bone and Bones; Bone Density Conservation Agents; Drug Design; Female; Osteoporosis; Phenylacetates; Prodrugs; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP4 Subtype | 2012 |